You are here:   Investor Relations * Advisers & Registrar

Investors Contact

Corporate Advisers & Registrar

Advisors and Registrar
Advisor Type / Registrar
 Details
Nominated Adviser & Joint Broker Allenby Capital Limited 
5 St Helen's Pl
London
EC3A 6AB
United Kingdom

+44 203 328 5656 
Joint Broker Stifel Nicolaus Europe Limited
150 Cheapside
London
EC2V 6ET
United Kingdom

+44 207 710 7600
Auditor RPG Crouch Chapman LLP
62 Wilson Street
London
EC2A 2BU
United Kingdom

+44 207 782 0007
+44 207 782 0939
Financial PR Walbrook PR
4 Lombard Street
London
EC3V 9HD
United Kingdom

+44 207 933 8780
+44 207 933 8781
 Registrar Link Asset Services
65 Gresham Street
London
EC2V 7NQ

+44 870 402 7570


Alternatively, please feel free to contact us on any topic anytime at ir@advancedoncotherapy.com.

Investor Relations
Investor News Alert Service

Subscribe to our investor alert service and receive all press releases as soon as they become available. Please enter your email address in the box below. You will receive an email confirming your registration.

This Email Alert service is provided by Walbrook PR on behalf of AVO. AVO and Walbrook PR respect your privacy. We promise not to share, rent or sell the information we collect from you, outside of making it periodically available to AVO. Your data is stored securely.
Research Interests
Technology
Company
Investor Relations

Company Number: 05564418 Registered England/Wales

Copyright 2019 by Advanced Oncotherapy

Site by Purple Creative Studio - Login

The presentation of the AVO's LIGHT Proton Therapy Solution is part of our Development roadmap and is subject to conformity assessment(s) by AVO's Notified Body as well as 510(k) clearance by the USA-FDA
Terms of Use Privacy Statement